The five mistakes that kill new supplement brands

We manufacture for a lot of new brands, which means we also watch a lot of them fail. The pattern is consistent enough to be worth writing down.

Almost none of them fail because the product was bad. They fail for one of five reasons, all of which are decided before a single unit is manufactured.

1. Launching one product

The most common error by a wide margin.

The logic seems sound: start small, prove the concept, expand later. In practice a single-SKU brand is structurally disadvantaged in three ways at once.

No cart-building. Your average order value is capped at one unit. A customer who wanted to spend more cannot.

No cross-sell. When someone buys and is satisfied, you have nothing to offer them next. The most valuable customer you have, one who already trusts you, hits a dead end.

No routine. Customers in this industry buy routines, not products. A hair-fall customer wants an oil and a tablet. A metabolic customer wants a tablet, a juice and something for the morning. Offering one piece of that means they buy the rest from someone else, and that someone else becomes their brand.

What to do instead: three or four SKUs that form a coherent routine in one category. Not four unrelated products, a routine. Tablet plus oil plus shampoo for hair. Tablet plus juice plus churna for liver. The second SKU typically costs you far less than the first in marketing terms, because it sells to an audience you already have.

2. Entering the biggest category

Weight management, men’s wellness and general immunity are the three largest categories in Indian supplements. They are also where a new brand with no audience has the least chance.

The problem is not that these categories are bad. It is that acquisition cost in them is set by whoever is spending the most, and in those three that is companies with budgets you cannot match. You end up paying ₹600 to acquire a customer for a ₹700 product.

Meanwhile: piles, uric acid, thyroid wellness, PCOS, kidney stones, varicose veins and cervical pain all have substantial Hindi search demand, motivated buyers, and almost nobody writing decent content for them. Smaller categories, far cheaper to enter, and winnable.

The test to apply: search your intended category in Hindi and look at what ranks. If the first page is well-made content from well-funded brands, that is an expensive fight. If it is thin, scraped or absent, that is an opportunity.

3. Building the brand before the audience

This is the one that costs the most money fastest.

The usual sequence: register the company, design a logo, commission packaging, place a large first order, build a website, then start thinking about how to reach customers.

By the time anyone asks where the customers come from, the money is in inventory.

The inverted sequence that works better: publish content first, in the language your category’s demand is actually in. Build some audience. Then manufacture against evidence of what that audience asks for.

Content needs weeks to index and rank. If you publish in September, you are earning traffic by the time November stock arrives. If you publish when stock lands, you wait another two months with capital tied up.

This costs almost nothing except sequencing, and it is the single most common thing new brands get backwards.

4. Making claims that cannot be printed

This one does not kill slowly. It kills overnight.

Three enforcement mechanisms move faster than any regulator:

• Marketplaces remove listings that promise health outcomes
• Ad platforms ban accounts, often permanently, for repeat claims violations
• Customers who were promised a cure leave reviews you cannot recover from

A brand that loses its ad account in week three of a launch, with stock on hand and a payment due, is usually finished. We have watched it happen.

The claims that do it: weight figures in kilograms, cure or treatment claims, sexual-performance promises, regrowth claims for pattern baldness, skin-whitening positioning, before-and-after imagery implying guaranteed results.

What works instead: traditional use of herbs, composition and ingredient levels, structure-function wording where a nutrient has recognised standing, and general wellness positioning. This is almost always sufficient, and it is what the brands that are still trading in five years use.

We decline artwork that crosses the line, and we review every label free before plates are made. Use the review, it costs you nothing and it catches exactly this.

5. Ordering more stock than you can sell

The pitch is seductive: order four times the minimum and the per-unit cost drops meaningfully.

What it actually does is convert your working capital into inventory with an expiry date.

Two things go wrong. First, you now have nothing left to spend on reaching customers, which is what actually sells the stock. Second, shelf life is finite, 18 to 24 months on most of our range, and stock that does not move becomes a write-off rather than a discount opportunity.

Our rule of thumb: no more than about 60% of your launch budget into the first stock order. The rest is the runway you need to sell it.

And size against demand, not against price breaks. If you cannot articulate how you will sell 20,000 units within shelf life, order 5,000 and reorder. Repeat orders on unchanged artwork ship in three to four weeks, the flexibility is worth more than the discount.

The sixth one, which is really a version of number three

Worth adding because it is seasonal and specific: ordering inside a season instead of ahead of it.

A brand that places a joint-care order in December is selling in February, into a falling market. They discount to clear, train their earliest customers to wait for discounts, and conclude the category is weak.

Count back: eight to ten weeks for a new SKU, three to four for a repeat. Weight management needs stock landed by late November for January. Respiratory needs early October. Summer electrolytes need late February.

We will tell you when a window has closed rather than take the order. The seasonal calendar has the full version.

What does not kill brands

Worth saying, because people worry about the wrong things.

Selling the same formulation as someone else. Customers choose brands on content, packaging and trust far more than on composition. Private label exists precisely so you can test the market before spending on development.

Not having a custom formulation. See above. Develop custom products from revenue, against evidence, not from the launch budget against a hunch.

Being small. Small brands with a defined audience in an under-served category do fine. Small brands trying to compete in weight management do not.

A competitor appearing. If your position depends on nobody else existing, the position was not real.

The uncomfortable summary

Every one of these is decided before manufacturing starts, which means every one is avoidable at zero cost.

1. Launch a routine, not a product
2. Pick a category you can actually win, not the biggest one
3. Build audience before inventory
4. Write claims that survive review
5. Keep 40% of your budget out of the first stock order

If you do those five things, you are ahead of most new entrants in this industry regardless of how good your product is. If you do none of them, a very good product will not save you.

The full sequence is in how to start a supplement brand in India, and the arithmetic in costing and margins.